aluates Reports

$ 0.0

Automative

Anti-Obesity Prescription Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-17R7098

Global Anti Obesity Prescription Drugs Market Insights and Forecast to 2028

BUY CHAPTERS

Anti-Obesity Prescription Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-17R7098

Report

September 2024

Pages:104

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

F Hoffmann La Roche Ltd

Orexigen Therapeutics

Novo Nordisk A S

Arena Pharmaceuticals

GlaxoSmithKline PLC

VIVUS

Boehringer Ingelheim

Alizyme

Anti-Obesity Prescription Drugs - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Anti-Obesity Prescription Drugs - Market

Growing demand for obesity is one of the recent trends in the global Anti-Obesity Prescription Drugs market. Moreover, this trend is further anticipated to drive the global Anti-Obesity Prescription Drugs market over the forecast period. Furthermore, growing obesity due unhealthy food and lifestyle such as intake of drugs due to stress, alcohol leads to growing demand for obesity management resulting in growth of this trend.

The global market for Anti-Obesity Prescription Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-Obesity Prescription Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Anti-Obesity Prescription Drugs by region & country, by Type, and by Application.

The Anti-Obesity Prescription Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Obesity Prescription Drugs.

Market Segmentation

Scope of Anti-Obesity Prescription Drugs - Market Report

Report Metric	Details
Report Name	Anti-Obesity Prescription Drugs - Market
CAGR	5%
Segment by Type:	Pediatric Adult
Segment by Application	Hospitals Pharmacies Retail Pharmacies E-commerce
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	F Hoffmann La Roche Ltd, Orexigen Therapeutics, Novo Nordisk A/s, Arena Pharmaceuticals, Glaxosmithkline, Vivus, Boehringer Ingelheim, Alizyme
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Anti-Obesity Prescription Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Anti-Obesity Prescription Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Anti-Obesity Prescription Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Anti-Obesity Prescription Drugs - Market report?

Ans: The main players in the Anti-Obesity Prescription Drugs - Market are F Hoffmann La Roche Ltd, Orexigen Therapeutics, Novo Nordisk A/s, Arena Pharmaceuticals, Glaxosmithkline, Vivus, Boehringer Ingelheim, Alizyme

What are the Application segmentation covered in the Anti-Obesity Prescription Drugs - Market report?

Ans: The Applications covered in the Anti-Obesity Prescription Drugs - Market report are Hospitals Pharmacies, Retail Pharmacies, E-commerce

What are the Type segmentation covered in the Anti-Obesity Prescription Drugs - Market report?

Ans: The Types covered in the Anti-Obesity Prescription Drugs - Market report are Pediatric, Adult

Recommended Reports

Prescription Drug Markets

Chronic and Metabolic Diseases

Therapeutic Areas & Treatments

1 Market Overview

1.1 Anti-Obesity Prescription Drugs Product Introduction

1.2 Global Anti-Obesity Prescription Drugs Market Size Forecast

1.2.1 Global Anti-Obesity Prescription Drugs Sales Value (2019-2030)

1.2.2 Global Anti-Obesity Prescription Drugs Sales Volume (2019-2030)

1.2.3 Global Anti-Obesity Prescription Drugs Sales Price (2019-2030)

1.3 Anti-Obesity Prescription Drugs Market Trends & Drivers

1.3.1 Anti-Obesity Prescription Drugs Industry Trends

1.3.2 Anti-Obesity Prescription Drugs Market Drivers & Opportunity

1.3.3 Anti-Obesity Prescription Drugs Market Challenges

1.3.4 Anti-Obesity Prescription Drugs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Anti-Obesity Prescription Drugs Players Revenue Ranking (2023)

2.2 Global Anti-Obesity Prescription Drugs Revenue by Company (2019-2024)

2.3 Global Anti-Obesity Prescription Drugs Players Sales Volume Ranking (2023)

2.4 Global Anti-Obesity Prescription Drugs Sales Volume by Company Players (2019-2024)

2.5 Global Anti-Obesity Prescription Drugs Average Price by Company (2019-2024)

2.6 Key Manufacturers Anti-Obesity Prescription Drugs Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Anti-Obesity Prescription Drugs Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Anti-Obesity Prescription Drugs

2.9 Anti-Obesity Prescription Drugs Market Competitive Analysis

2.9.1 Anti-Obesity Prescription Drugs Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Anti-Obesity Prescription Drugs Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Obesity Prescription Drugs as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Pediatric

3.1.2 Adult

3.2 Global Anti-Obesity Prescription Drugs Sales Value by Type

3.2.1 Global Anti-Obesity Prescription Drugs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Anti-Obesity Prescription Drugs Sales Value, by Type (2019-2030)

3.2.3 Global Anti-Obesity Prescription Drugs Sales Value, by Type (%) (2019-2030)

3.3 Global Anti-Obesity Prescription Drugs Sales Volume by Type

3.3.1 Global Anti-Obesity Prescription Drugs Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Anti-Obesity Prescription Drugs Sales Volume, by Type (2019-2030)

3.3.3 Global Anti-Obesity Prescription Drugs Sales Volume, by Type (%) (2019-2030)

3.4 Global Anti-Obesity Prescription Drugs Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals Pharmacies

4.1.2 Retail Pharmacies

4.1.3 E-commerce

4.2 Global Anti-Obesity Prescription Drugs Sales Value by Application

4.2.1 Global Anti-Obesity Prescription Drugs Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Anti-Obesity Prescription Drugs Sales Value, by Application (2019-2030)

4.2.3 Global Anti-Obesity Prescription Drugs Sales Value, by Application (%) (2019-2030)

4.3 Global Anti-Obesity Prescription Drugs Sales Volume by Application

4.3.1 Global Anti-Obesity Prescription Drugs Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Anti-Obesity Prescription Drugs Sales Volume, by Application (2019-2030)

4.3.3 Global Anti-Obesity Prescription Drugs Sales Volume, by Application (%) (2019-2030)

4.4 Global Anti-Obesity Prescription Drugs Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Anti-Obesity Prescription Drugs Sales Value by Region

5.1.1 Global Anti-Obesity Prescription Drugs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Anti-Obesity Prescription Drugs Sales Value by Region (2019-2024)

5.1.3 Global Anti-Obesity Prescription Drugs Sales Value by Region (2025-2030)

5.1.4 Global Anti-Obesity Prescription Drugs Sales Value by Region (%), (2019-2030)

5.2 Global Anti-Obesity Prescription Drugs Sales Volume by Region

5.2.1 Global Anti-Obesity Prescription Drugs Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Anti-Obesity Prescription Drugs Sales Volume by Region (2019-2024)

5.2.3 Global Anti-Obesity Prescription Drugs Sales Volume by Region (2025-2030)

5.2.4 Global Anti-Obesity Prescription Drugs Sales Volume by Region (%), (2019-2030)

5.3 Global Anti-Obesity Prescription Drugs Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Anti-Obesity Prescription Drugs Sales Value, 2019-2030

5.4.2 North America Anti-Obesity Prescription Drugs Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Anti-Obesity Prescription Drugs Sales Value, 2019-2030

5.5.2 Europe Anti-Obesity Prescription Drugs Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Anti-Obesity Prescription Drugs Sales Value, 2019-2030

5.6.2 Asia Pacific Anti-Obesity Prescription Drugs Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Anti-Obesity Prescription Drugs Sales Value, 2019-2030

5.7.2 South America Anti-Obesity Prescription Drugs Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Anti-Obesity Prescription Drugs Sales Value, 2019-2030

5.8.2 Middle East & Africa Anti-Obesity Prescription Drugs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Anti-Obesity Prescription Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Anti-Obesity Prescription Drugs Sales Value

6.2.1 Key Countries/Regions Anti-Obesity Prescription Drugs Sales Value, 2019-2030

6.2.2 Key Countries/Regions Anti-Obesity Prescription Drugs Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Anti-Obesity Prescription Drugs Sales Value, 2019-2030

6.3.2 United States Anti-Obesity Prescription Drugs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Anti-Obesity Prescription Drugs Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Anti-Obesity Prescription Drugs Sales Value, 2019-2030

6.4.2 Europe Anti-Obesity Prescription Drugs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Anti-Obesity Prescription Drugs Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Anti-Obesity Prescription Drugs Sales Value, 2019-2030

6.5.2 China Anti-Obesity Prescription Drugs Sales Value by Type (%), 2023 VS 2030

6.5.3 China Anti-Obesity Prescription Drugs Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Anti-Obesity Prescription Drugs Sales Value, 2019-2030

6.6.2 Japan Anti-Obesity Prescription Drugs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Anti-Obesity Prescription Drugs Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Anti-Obesity Prescription Drugs Sales Value, 2019-2030

6.7.2 South Korea Anti-Obesity Prescription Drugs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Anti-Obesity Prescription Drugs Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Anti-Obesity Prescription Drugs Sales Value, 2019-2030

6.8.2 Southeast Asia Anti-Obesity Prescription Drugs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Anti-Obesity Prescription Drugs Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Anti-Obesity Prescription Drugs Sales Value, 2019-2030

6.9.2 India Anti-Obesity Prescription Drugs Sales Value by Type (%), 2023 VS 2030

6.9.3 India Anti-Obesity Prescription Drugs Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 F Hoffmann La Roche Ltd

7.1.1 F Hoffmann La Roche Ltd Company Information

7.1.2 F Hoffmann La Roche Ltd Introduction and Business Overview

7.1.3 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)

7.1.4 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Product Offerings

7.1.5 F Hoffmann La Roche Ltd Recent Development

7.2 Orexigen Therapeutics

7.2.1 Orexigen Therapeutics Company Information

7.2.2 Orexigen Therapeutics Introduction and Business Overview

7.2.3 Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Orexigen Therapeutics Anti-Obesity Prescription Drugs Product Offerings

7.2.5 Orexigen Therapeutics Recent Development

7.3 Novo Nordisk A/s

7.3.1 Novo Nordisk A/s Company Information

7.3.2 Novo Nordisk A/s Introduction and Business Overview

7.3.3 Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Novo Nordisk A/s Anti-Obesity Prescription Drugs Product Offerings

7.3.5 Novo Nordisk A/s Recent Development

7.4 Arena Pharmaceuticals

7.4.1 Arena Pharmaceuticals Company Information

7.4.2 Arena Pharmaceuticals Introduction and Business Overview

7.4.3 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Product Offerings

7.4.5 Arena Pharmaceuticals Recent Development

7.5 Glaxosmithkline

7.5.1 Glaxosmithkline Company Information

7.5.2 Glaxosmithkline Introduction and Business Overview

7.5.3 Glaxosmithkline Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Glaxosmithkline Anti-Obesity Prescription Drugs Product Offerings

7.5.5 Glaxosmithkline Recent Development

7.6 Vivus

7.6.1 Vivus Company Information

7.6.2 Vivus Introduction and Business Overview

7.6.3 Vivus Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Vivus Anti-Obesity Prescription Drugs Product Offerings

7.6.5 Vivus Recent Development

7.7 Boehringer Ingelheim

7.7.1 Boehringer Ingelheim Company Information

7.7.2 Boehringer Ingelheim Introduction and Business Overview

7.7.3 Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Boehringer Ingelheim Anti-Obesity Prescription Drugs Product Offerings

7.7.5 Boehringer Ingelheim Recent Development

7.8 Alizyme

7.8.1 Alizyme Company Information

7.8.2 Alizyme Introduction and Business Overview

7.8.3 Alizyme Anti-Obesity Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Alizyme Anti-Obesity Prescription Drugs Product Offerings

7.8.5 Alizyme Recent Development

8 Industry Chain Analysis

8.1 Anti-Obesity Prescription Drugs Industrial Chain

8.2 Anti-Obesity Prescription Drugs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Anti-Obesity Prescription Drugs Sales Model

8.5.2 Sales Channel

8.5.3 Anti-Obesity Prescription Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

F Hoffmann La Roche Ltd

Orexigen Therapeutics

Novo Nordisk A S

Arena Pharmaceuticals

GlaxoSmithKline PLC

VIVUS

Boehringer Ingelheim

Alizyme

List of Tables

Table 1. Anti-Obesity Prescription Drugs Market Trends

Table 2. Anti-Obesity Prescription Drugs Market Drivers & Opportunity

Table 3. Anti-Obesity Prescription Drugs Market Challenges

Table 4. Anti-Obesity Prescription Drugs Market Restraints

Table 5. Global Anti-Obesity Prescription Drugs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Anti-Obesity Prescription Drugs Revenue Market Share by Company (2019-2024)

Table 7. Global Anti-Obesity Prescription Drugs Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Anti-Obesity Prescription Drugs Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Anti-Obesity Prescription Drugs Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Anti-Obesity Prescription Drugs Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Anti-Obesity Prescription Drugs Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Anti-Obesity Prescription Drugs

Table 13. Global Anti-Obesity Prescription Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Obesity Prescription Drugs as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Anti-Obesity Prescription Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Anti-Obesity Prescription Drugs Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Anti-Obesity Prescription Drugs Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Anti-Obesity Prescription Drugs Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Anti-Obesity Prescription Drugs Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Anti-Obesity Prescription Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Anti-Obesity Prescription Drugs Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Anti-Obesity Prescription Drugs Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Anti-Obesity Prescription Drugs Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Anti-Obesity Prescription Drugs Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Anti-Obesity Prescription Drugs Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Anti-Obesity Prescription Drugs Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Anti-Obesity Prescription Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Anti-Obesity Prescription Drugs Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Anti-Obesity Prescription Drugs Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Anti-Obesity Prescription Drugs Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Anti-Obesity Prescription Drugs Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Anti-Obesity Prescription Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Anti-Obesity Prescription Drugs Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Anti-Obesity Prescription Drugs Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Anti-Obesity Prescription Drugs Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Anti-Obesity Prescription Drugs Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Anti-Obesity Prescription Drugs Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Anti-Obesity Prescription Drugs Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Anti-Obesity Prescription Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Anti-Obesity Prescription Drugs Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Anti-Obesity Prescription Drugs Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Anti-Obesity Prescription Drugs Sales Value by Region (2019-2024) & (%)

Table 44. Global Anti-Obesity Prescription Drugs Sales Value by Region (2025-2030) & (%)

Table 45. Global Anti-Obesity Prescription Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Anti-Obesity Prescription Drugs Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Anti-Obesity Prescription Drugs Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Anti-Obesity Prescription Drugs Sales Volume by Region (2019-2024) & (%)

Table 49. Global Anti-Obesity Prescription Drugs Sales Volume by Region (2025-2030) & (%)

Table 50. Global Anti-Obesity Prescription Drugs Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Anti-Obesity Prescription Drugs Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Anti-Obesity Prescription Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Anti-Obesity Prescription Drugs Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Anti-Obesity Prescription Drugs Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Anti-Obesity Prescription Drugs Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Anti-Obesity Prescription Drugs Sales Volume, (2025-2030) & (K Units)

Table 57. F Hoffmann La Roche Ltd Company Information

Table 58. F Hoffmann La Roche Ltd Introduction and Business Overview

Table 59. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Product Offerings

Table 61. F Hoffmann La Roche Ltd Recent Development

Table 62. Orexigen Therapeutics Company Information

Table 63. Orexigen Therapeutics Introduction and Business Overview

Table 64. Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Orexigen Therapeutics Anti-Obesity Prescription Drugs Product Offerings

Table 66. Orexigen Therapeutics Recent Development

Table 67. Novo Nordisk A/s Company Information

Table 68. Novo Nordisk A/s Introduction and Business Overview

Table 69. Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Novo Nordisk A/s Anti-Obesity Prescription Drugs Product Offerings

Table 71. Novo Nordisk A/s Recent Development

Table 72. Arena Pharmaceuticals Company Information

Table 73. Arena Pharmaceuticals Introduction and Business Overview

Table 74. Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Arena Pharmaceuticals Anti-Obesity Prescription Drugs Product Offerings

Table 76. Arena Pharmaceuticals Recent Development

Table 77. Glaxosmithkline Company Information

Table 78. Glaxosmithkline Introduction and Business Overview

Table 79. Glaxosmithkline Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Glaxosmithkline Anti-Obesity Prescription Drugs Product Offerings

Table 81. Glaxosmithkline Recent Development

Table 82. Vivus Company Information

Table 83. Vivus Introduction and Business Overview

Table 84. Vivus Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Vivus Anti-Obesity Prescription Drugs Product Offerings

Table 86. Vivus Recent Development

Table 87. Boehringer Ingelheim Company Information

Table 88. Boehringer Ingelheim Introduction and Business Overview

Table 89. Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Boehringer Ingelheim Anti-Obesity Prescription Drugs Product Offerings

Table 91. Boehringer Ingelheim Recent Development

Table 92. Alizyme Company Information

Table 93. Alizyme Introduction and Business Overview

Table 94. Alizyme Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Alizyme Anti-Obesity Prescription Drugs Product Offerings

Table 96. Alizyme Recent Development

Table 97. Key Raw Materials Lists

Table 98. Raw Materials Key Suppliers Lists

Table 99. Anti-Obesity Prescription Drugs Downstream Customers

Table 100. Anti-Obesity Prescription Drugs Distributors List

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Anti-Obesity Prescription Drugs Product Picture

Figure 2. Global Anti-Obesity Prescription Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Anti-Obesity Prescription Drugs Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Anti-Obesity Prescription Drugs Sales Volume (2019-2030) & (K Units)

Figure 5. Global Anti-Obesity Prescription Drugs Sales Price (2019-2030) & (US$/Unit)

Figure 6. Anti-Obesity Prescription Drugs Report Years Considered

Figure 7. Global Anti-Obesity Prescription Drugs Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Anti-Obesity Prescription Drugs Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Obesity Prescription Drugs Revenue in 2023

Figure 10. Anti-Obesity Prescription Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Pediatric Picture

Figure 12. Adult Picture

Figure 13. Global Anti-Obesity Prescription Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Anti-Obesity Prescription Drugs Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Anti-Obesity Prescription Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Anti-Obesity Prescription Drugs Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Anti-Obesity Prescription Drugs Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Hospitals Pharmacies

Figure 19. Product Picture of Retail Pharmacies

Figure 20. Product Picture of E-commerce

Figure 21. Global Anti-Obesity Prescription Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Anti-Obesity Prescription Drugs Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Anti-Obesity Prescription Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Anti-Obesity Prescription Drugs Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Anti-Obesity Prescription Drugs Price by Application (2019-2030) & (US$/Unit)

Figure 26. North America Anti-Obesity Prescription Drugs Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Anti-Obesity Prescription Drugs Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Anti-Obesity Prescription Drugs Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Anti-Obesity Prescription Drugs Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Anti-Obesity Prescription Drugs Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Anti-Obesity Prescription Drugs Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Anti-Obesity Prescription Drugs Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Anti-Obesity Prescription Drugs Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Anti-Obesity Prescription Drugs Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Anti-Obesity Prescription Drugs Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Anti-Obesity Prescription Drugs Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Anti-Obesity Prescription Drugs Sales Volume (%), (2019-2030)

Figure 38. United States Anti-Obesity Prescription Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Anti-Obesity Prescription Drugs Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Anti-Obesity Prescription Drugs Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Anti-Obesity Prescription Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Anti-Obesity Prescription Drugs Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Anti-Obesity Prescription Drugs Sales Value by Application (%), 2023 VS 2030

Figure 44. China Anti-Obesity Prescription Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Anti-Obesity Prescription Drugs Sales Value by Type (%), 2023 VS 2030

Figure 46. China Anti-Obesity Prescription Drugs Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Anti-Obesity Prescription Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Anti-Obesity Prescription Drugs Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Anti-Obesity Prescription Drugs Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Anti-Obesity Prescription Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Anti-Obesity Prescription Drugs Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Anti-Obesity Prescription Drugs Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Anti-Obesity Prescription Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Anti-Obesity Prescription Drugs Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Anti-Obesity Prescription Drugs Sales Value by Application (%), 2023 VS 2030

Figure 56. India Anti-Obesity Prescription Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Anti-Obesity Prescription Drugs Sales Value by Type (%), 2023 VS 2030

Figure 58. India Anti-Obesity Prescription Drugs Sales Value by Application (%), 2023 VS 2030

Figure 59. Anti-Obesity Prescription Drugs Industrial Chain

Figure 60. Anti-Obesity Prescription Drugs Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Prescription Diet Market Research Report 2024

Global Prescription Weight Loss Medications Market Research Report 2025

Global Obesity Diagnosis and Treatment Market Research Report 2024

Global Weight loss Drugs Market Insights Forecast to 2030

Anti Obesity Drugs Anti obesity Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Automated Prescription System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti Aging Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prescription Arthritis Medications Market Research Report 2024

Acne Prescription Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti myopia Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Malaria Prescription Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antiglaucoma Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti Obesity Compound Library Market Research Report 2025

Antidiabetic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Anti Diabetic Drug Market Insights Forecast to 2030

Global Weight Reduction Medicine Market Research Report 2024

Pharmaceutical Business Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Psychiatric Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions